Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Samual Lindemeier

Orthopaedic Surgery Fargo, ND Doctor of Osteopathy

NPI 1891181137 CMS profile 2782681

3000 32Nd Ave S, Fargo, ND 58103

Open in the dashboard

General payments

$4,212

56 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Samual Lindemeier of Fargo, ND is reported in the CMS Open Payments database as having received $4,212 across 56 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 53rd percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $426 7
2024 General $574 10
2023 General $443 9
2022 General $2,199 20
2021 General $444 7
2019 General $127 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Samual Lindemeier
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Samual Lindemeier were reported at $426. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Samual Lindemeier Orthopaedic Surgery median Middle half National median
2019 $127 $644 $140–$2,844 $163
2020 $0 $312 $75–$1,860 $114
2021 $444 $520 $117–$2,495 $132
2022 $2,199 $598 $128–$2,731 $149
2023 $443 $461 $128–$2,264 $160
2024 $574 $497 $134–$2,475 $164
2025 $426 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Zimmer Biomet Holdings, Inc. $3,000 34 payments
  2. Stryker Corporation $883 14 payments
  3. DePuy Synthes Sales Inc. $149 2 payments
  4. Medtronic USA, Inc. $77 1 payment
  5. Boston Scientific Corporation $50 2 payments
  6. MicroPort Orthopedics Inc $23 1 payment
  7. Heron Therapeutics, Inc. $15 1 payment
  8. Flexion Therapeutics, Inc. $15 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $2,580 46 payments
  2. Travel and Lodging $1,353 7 payments
  3. Education $280 3 payments
Products named General payments · program years 2019–2025
  1. ROSA Knees $1,541 12 payments
  2. Persona $330 8 payments
  3. MAKO $249 2 payments
  4. ORTHOLOC 3DI $234 5 payments
  5. GAMMA $231 4 payments
  6. Tapestry $212 4 payments
  7. TRIATHLON $175 1 payment
  8. Avenir $171 3 payments
  9. ROSA Hips $159 3 payments
  10. mymobility Platform $144 1 payment
  11. Other $1,275 35 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

221

Median for Osteopathic Manipulative Medicine: 311

Drug cost

$945

Median for Osteopathic Manipulative Medicine: $11,323

Branded share of claims

6.8%

Median for Osteopathic Manipulative Medicine: 19.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 26 $497
Meloxicam Generic 42 $110
Oxycodone Hcl Generic 37 $104
Tramadol Hcl Generic 42 $95
Cephalexin Generic 48 $72
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim Brand 15 $45
Dexamethasone Generic 11 $22

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 526 Part D prescribers listed as Osteopathic Manipulative Medicine; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 43 billing codes

Paid by Medicare

$167,939

Medicare's payments for the services billed

Medicare patients

290

Average age 74

Services billed

578

181 women, 109 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Chronic kidney disease 29%
Depression 28%
Diabetes 27%
Ischemic heart disease 25%
Heart failure 17%
Atrial fibrillation 17%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

56 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in North Dakota

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record